A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: next (883), subsequent (588)

Lenalidomide-RituximabIV/SC

Description
Chemotherapy Protocol LYMPHOMA LENALIDOMIDE-RITUXIMAB (IV/SC) There are multiple versions of this protocol in use. Please ensure you have the correct protocol f
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Lenalidomide-RituximabIVSC.pdf

Imatinib v1

Description
Chemotherapy Protocol SARCOMA Gastro-Intestinal Stromal Tumour (GIST) Imatinib Regimen GIST-Imatinib Indication Imatinib is recomme
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Imatinib-v1.pdf

Vemurafenib Ver 1

Description
Chemotherapy Protocol SKIN CANCER Regimen VEMURAFENIB Skin – Vemurafenib Indication Vemurafenib is recommended as an option for the treatment of BRAF m
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinVemurafenibVer1.pdf

MelanomaBleomycinECT

Description
ChemotherapApril 17y Protocol SKIN CANCER BLEOMYCIN (ELECTROCHEMOTHERAPY) Please note this protocol only refers to the administration of bleomycin in t
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/MelanomaBleomycinECT.pdf

Dacarbazine Ver 1

Description
Chemotherapy Protocol SKIN CANCER DACARBAZINE Regimen Skin – Dacarbazine Indication Dacarbazine is recommended as a first line option for unresectable
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinDacarbazineVer1.pdf

Dabrafenib Ver 1

Description
Chemotherapy Protocol SKIN CANCER DABRAFENIB Regimen Skin – Dabrafenib Indication Dabrafenib is recommended as an option for the first line treatment o
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/SkinDabrafenibVer1.pdf

Binimetinib-Encorafenib

Description
Chemotherapy Protocol SKIN CANCER Binimetinib-Encorafenib Regimen • Skin – Binimetinib-Encorafenib Indication • Unresectable or metastatic BRAF V600 mutation-positive melanoma where th
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Skincancer/Binimetinib-Encorafenib.pdf

Sorafenib version 1.1

Description
Chemotherapy Protocol LIVER SORAFENIB This protocol may require funding Regimen  Hepatocellular carcinoma-Sorafenib Indication  Hepatocellular carcinoma w
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Hepatobiliary/Sorafenib-version-1.1.pdf

Hydroxycarbamide

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia (CML) Hydroxycarbamide Regimen • CML - Hydroxycarbamide Indication • Chronic or accelerated
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/Hydroxycarbamide.pdf

DasatinibChronic

Description
Chemotherapy Protocol Chronic Myeloid Leukaemia DASATINIB (chronic phase) Funding may be required for specific indications Regimen • CML – Dasatinib (c
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CML/DasatinibChronic.pdf
291 to 300 of 1000
Previous … 28 29 30 31 32 … Next